Vossen A, van der Zee HH, Prens EP. Hidradenitis Suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model. Front Immunol. 2018;9:2965. https://doi.org/10.3389/fimmu.2018.02965.
Article CAS PubMed PubMed Central Google Scholar
Bechara FG, Podda M, Prens EP, Horváth B, Giamarellos-Bourboulis EJ, Alavi A, et al. Efficacy and safety of Adalimumab in Conjunction with surgery in moderate to severe Hidradenitis Suppurativa. JAMA Surg. 2021;156(11):1001. https://doi.org/10.1001/jamasurg.2021.3655.
Cuenca-Barrales C, Montero-Vílchez T, Sánchez-Díaz M, Martínez-López A, Rodríguez-Pozo JÁ, Díaz-Calvillo P, et al. Intralesional treatments in Hidradenitis Suppurativa: a systematic review. Dermatology. 2022;238(6):1084–91. https://doi.org/10.1159/000524121.
Riis PT, Boer J, Prens EP, Saunte DML, Deckers IE, Emtestam L, et al. Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series. J Am Acad Dermatol. 2016;75(6):1151–5. https://doi.org/10.1016/j.jaad.2016.06.049.
Article CAS PubMed Google Scholar
Álvarez P, Poveda F. José. Intralesional Triamcinolone for Fistulous tracts in Hidradenitis Suppurativa: an uncontrolled prospective trial with clinical and Ultrasonographic Follow-Up. Dermatology. 2020;236(1):46–51. https://doi.org/10.1159/000499934.
Article CAS PubMed Google Scholar
*Sechi A, Patrizi A, Raone B. Intralesional steroid injections to target sinus tract fibrosis in hidradenitis suppurativa: results from an ultrasound-based retrospective study. Dermatol Ther. 2022;35(9). https://doi.org/10.1111/dth.15710.
Salvador-Rodríguez L, Arias-Santiago S, Molina-Leyva A. Ultrasound-assisted intralesional corticosteroid infiltrations for patients with hidradenitis suppurativa. Sci Rep. 2020;10(1). https://doi.org/10.1038/s41598-020-70176-x.
Garelik J, Babbush K, Ghias M, Cohen SR. Efficacy of high-dose intralesional triamcinolone for hidradenitis suppurativa. Int J Dermatol. 2021;60(2):217–21. https://doi.org/10.1111/ijd.15124.
Article CAS PubMed Google Scholar
Sakhiya J, Sakhiya D, Kaklotar J, Hirapara B, Purohit M, Bhalala K, et al. Intralesional agents in Dermatology: pros and cons. J Cutan Aesthetic Surg. 2021;14(3):285–95. https://doi.org/10.4103/JCAS.JCAS_109_20.
Saunte DML, Jemec GBE. Intralesional Triamcinolone for Hidradenitis Suppurativa—How much is needed? Dermatol Surg. 2021;47(7):1013–4. https://doi.org/10.1097/dss.0000000000002753.
Article CAS PubMed Google Scholar
Danby FW, Hazen PG, Boer J. New and traditional surgical approaches to hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5):S62–5. https://doi.org/10.1016/j.jaad.2015.07.043.
Fajgenbaum K, Crouse L, Dong L, Zeng D, Sayed C. Intralesional Triamcinolone May not be beneficial for treating Acute Hidradenitis Suppurativa lesions: a Double-Blind, randomized, placebo-controlled trial. Dermatol Surgery: Official Publication Am Soc Dermatol Surg [et al]. 2020;46(5):685–9. https://doi.org/10.1097/DSS.0000000000002112.
Sukhumthammarat W, Putthapiban P, Sriphrapradang C. Local injection of Triamcinolone Acetonide: a Forgotten Aetiology of Cushing’s syndrome. J Clin Diagn Res. 2017;11(6):OR01–2. https://doi.org/10.7860/JCDR/2017/27238.10091.
Article PubMed PubMed Central Google Scholar
Dautriche CN, Mamalis A, Lai Y, Heilman E, Glick SA, Siegel D. Tumescent triamcinolone infiltration: a new approach for the management of recalcitrant hidradenitis suppurativa. JAAD Case Rep. 2020;6(12):1310–2. https://doi.org/10.1016/j.jdcr.2020.10.004.
Article PubMed PubMed Central Google Scholar
Shi W, Schultz S, Strouse A, Gater DR. Successful treatment of stage III hidradenitis suppurativa with botulinum toxin A. BMJ Case Rep. 2019;12(1):e226064. https://doi.org/10.1136/bcr-2018-226064.
Article PubMed PubMed Central Google Scholar
Fragoso NM, Masson R, Gillenwater TJ, Shi VY, Hsiao JL. Emerging treatments and the clinical Trial Landscape for Hidradenitis Suppurativa—Part II: procedural and Wound Care therapies. Dermatology Therapy. 2023;13(8):1699–720. https://doi.org/10.1007/s13555-023-00957-5.
Article PubMed PubMed Central Google Scholar
Geoghegan L, Rodrigues R, Harrison CJ, Rodrigues JN. The Use of Botulinum Toxin in the management of Hidradenitis Suppurativa: a systematic review. Plast Reconstr Surg Glob Open. 2022;10(11):e4660. https://doi.org/10.1097/GOX.0000000000004660.
Article PubMed PubMed Central Google Scholar
Grimstad Ø, Kvammen BØ, Swartling C. Botulinum Toxin Type B for Hidradenitis Suppurativa: a Randomised, Double-Blind, placebo-controlled pilot study. Am J Clin Dermatol. 2020;21(5):741–8. https://doi.org/10.1007/s40257-020-00537-9.
Article PubMed PubMed Central Google Scholar
Qu H, Gao L. Botulinum toxin type A for the management of hidradenitis suppurativa. Am J Transl Res. 2021;13(12):14115–20.
CAS PubMed PubMed Central Google Scholar
Revankar RR, Blum F, Yeung H, Patel HA, Holahan H, Vedak P, et al. Factors influencing patient experience during incision and drainage procedures in hidradenitis suppurativa: an analysis of patient-reported outcomes. Br J Dermatol. 2023;189(6):779–80. https://doi.org/10.1093/bjd/ljad327.
Janse I, Bieniek A, Horváth B, Matusiak Ł. Surgical procedures in Hidradenitis Suppurativa. Dermatol Clin. 2016;34(1):97–109. https://doi.org/10.1016/j.det.2015.08.007.
Article CAS PubMed Google Scholar
Panayi AC, Matar DY, Haug V, Wu M, Orgill DP. Characteristics and outcomes of patients undergoing Surgical Management of Hidradenitis Suppurativa: an ACS-NSQIP Data Analysis. Adv Wound care. 2023;12(5):256–68. https://doi.org/10.1089/wound.2021.0132.
Ruan QZ, Chen AD, Singhal D, Lee BT, Fukudome EY. Surgical management of hidradenitis suppurativa: procedural trends and risk factors. J Surg Res. 2018;229:200–7. https://doi.org/10.1016/j.jss.2018.04.007.
Blum FR, Paci KM, Sayed CJ. Use of a punch biopsy tool as an alternative approach for incision and drainage of abscesses. J Am Acad Dermatol. 2022;86(4):e141–2. https://doi.org/10.1016/j.jaad.2021.11.005.
Mohamedahmed AYY, Zaman S, Stonelake S, Ahmad AN, Datta U, Hajibandeh S, et al. Incision and drainage of cutaneous abscess with or without cavity packing: a systematic review, meta-analysis, and trial sequential analysis of randomised controlled trials. Langenbeck’s Archives Surg. 2021;406(4):981–91. https://doi.org/10.1007/s00423-020-01941-9.
Ravi S, Miles JA, Steele C, Christiansen MK, Sayed CJ. Patient impressions and outcomes after clinic-based Hidradenitis Suppurativa surgery. JAMA Dermatology. 2022;158(2):132. https://doi.org/10.1001/jamadermatol.2021.4741.
Article PubMed PubMed Central Google Scholar
Mehdizadeh A, Hazen PG, Bechara FG, Zwingerman N, Moazenzadeh M, Bashash M, et al. Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(5):S70–7. https://doi.org/10.1016/j.jaad.2015.07.044.
Von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011;164(2):367–71. https://doi.org/10.1111/j.1365-2133.2010.10034.x.
Van Der Zee HH, Prens EP, Boer J, Deroofing. A tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. J Am Acad Dermatol. 2010;63(3):475–80. https://doi.org/10.1016/j.jaad.2009.12.018.
Bui H, Bechara FG, George R, Goldberg S, Hamzavi I, Kirby JS, et al. Surgical Procedural definitions for Hidradenitis Suppurativa developed by Expert Delphi Consensus. JAMA Dermatology. 2023;159(4):441. https://doi.org/10.1001/jamadermatol.2022.6266.
Hengy M, Daveluy S. A simple video demonstrating the deroofing technique for hidradenitis suppurativa. J Am Acad Dermatol. 2024;90(3):e89. https://doi.org/10.1016/j.jaad.2022.11.011.
留言 (0)